CHE — CHEMED CORP
—
NYSE ·
Health Care ·
Health Care Providers & Services ·
CIK 19584 ·
Last close
$546.75
Market Cap
$7.09B
52W High
$561.52
52W Low
$363.77
ADV30
148,955
Next earnings
2026-10-27
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | — | — | — | — | — | — | — |
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | 657,513,000 | 215,764,000 | 84,578,000 | 66,302,000 | 1,535,815,000 | 16,856,000 | 687,821,000 |
| Dec 2025 | 639,337,000 | 225,171,000 | 103,563,000 | 76,751,000 | 1,538,189,000 | 74,515,000 | 558,784,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$443,747,000
Investing CF
$-83,455,000
Financing CF
$-517,318,000
CapEx
$-66,631,000
Dividends Paid
$-32,543,000
Buybacks
$-588,317,000
EPS Diluted TTM
$20.90
As of
2026-11-01
Balance + Analyst (yfinance extras)
Retained Earnings
$3,013,504,000
Inventory
$7,208,000
Receivables
$215,479,000
ST Investments
—
EBIT TTM
$350,877,000
Pretax Income TTM
$348,944,000
Interest Exp TTM
$1,933,000
Analysts
5
Yahoo Snapshot (yfinance, live)
Total Revenue
$2,661,040,896
EBITDA
$439,756,992
Free Cash Flow
$262,595,504
Enterprise Value
$7,326,140,928
Total Cash
$48,427,000
Total Debt
$392,193,984
Shares Out
12,959,956
Trailing EPS
$20.88
Book Value
$65.97
ROE
29.1%
ROA
14.1%
Div Yield
0.52%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 2,529,978,000 | 341,155,000 | 265,238,000 | 1,538,189,000 | 558,784,000 | 979,405,000 | 388,272,000 |
| Dec 2024 | 2,431,287,000 | 366,939,000 | 301,999,000 | 1,668,575,000 | 549,582,000 | 1,118,993,000 | 417,497,000 |
| Dec 2023 | 2,264,417,000 | 342,830,000 | 272,509,000 | 1,668,095,000 | 560,219,000 | 1,107,876,000 | 330,299,000 |
| Dec 2022 | 2,134,963,000 | 347,187,000 | 249,624,000 | 1,442,012,000 | 643,297,000 | 798,715,000 | 309,886,000 |
TTM Snapshot
Revenues TTM
$2,595,001,000
NetIncome TTM
$274,993,000
OpCashFlow TTM
—
Assets (Latest)
$1,579,585,000
Forward EPS
$27.85
Max Pain — expiry 2027-03-19 (volume-derived — Yahoo OI feed degraded)
max pain strike: $600.00 · spot: $546.72 · call volume: 40 · put volume: 2,516Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| PACS | PACS Group, Inc. | $7.71B | $48.55 | — |
| RDNT | RadNet, Inc. | $5.90B | $74.92 | — |
| CAI | Caris Life Sciences, Inc. | $5.72B | $19.94 | — |
| LFST | LifeStance Health Group, Inc. | $5.39B | $14.17 | — |
| CON | Concentra Group Holdings Parent, Inc. | $5.36B | $42.38 | — |
News headlines (Yahoo Finance, 1h cache)
Chemed: 3 Key Takeaways for Long-Term Investors
2026-11-17 18:50 · Yahoo
Chemed Corporation Declares Quarterly Dividend of 70 Cents
2026-11-06 16:23 · Yahoo
Chemed Corporation to Present at the UBS 2026 Global Healthcare Conference
2026-11-02 14:00 · Yahoo
CHE Q3 deep dive: VITAS and Roto-Rooter drive revenue growth, margin headwinds persist
2026-10-30 21:39 · Yahoo
Chemed (CHE) Looks Repriced As Raised Guidance And Margin Gains Lift The Narrative
2026-10-30 14:11 · Yahoo
5 insightful analyst questions from Chemed’s Q3 earnings call
2026-10-30 09:15 · Yahoo
Chemed (CHE) Stock Gets Fair Value Bump As Vitas Strength Offsets Roto Concerns
2026-10-30 04:30 · Yahoo
What Chemed (CHE) Said on Its Q3 Earnings Call
2026-10-29 07:04 · Yahoo
Chemed: Q3 Earnings Snapshot
2026-10-28 18:34 · Yahoo
LH Stock Hits Record Levels, CHE Stock Surges To Over 52-Week Highs – Here’s What’s Driving Investor Enthusiasm
2026-10-28 17:56 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.